Literature DB >> 5727783

Relative potency of commercial secretins.

G F Stening, M Vagne, M I Grossman.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 5727783

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  9 in total

1.  The relative potency of the Crick-Harper-Raper unit and the GIH clinical unit of secretin.

Authors:  J M Braganza; H T Howat; G Kay
Journal:  Gut       Date:  1975-07       Impact factor: 23.059

Review 2.  The Lundh test.

Authors:  O James
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

Review 3.  Progess report. Is secretin secreted?

Authors:  K G Wormsley
Journal:  Gut       Date:  1973-09       Impact factor: 23.059

Review 4.  The control of pancreatic secretion.

Authors:  A A Harper
Journal:  Gut       Date:  1972-04       Impact factor: 23.059

5.  The excretion of 5,5-dimethyl-2,4-oxazolidinedione from the canine pancreas and liver.

Authors:  A Noda; Y Toda; T Hayakawa; S Nakajima
Journal:  Am J Dig Dis       Date:  1973-06

6.  Comparison of the pancreozymin-secretin test and the Lundh test meal.

Authors:  D D Moeller; G D Dunn; A P Klotz
Journal:  Am J Dig Dis       Date:  1972-09

7.  Comparison of pancreatic responses to natural and synthetic secretins in conscious cats.

Authors:  S J Konturek
Journal:  Am J Dig Dis       Date:  1969-08

8.  Effects of parenteral secretin--cholecystokinin and of duodenal acid perfusion on gastric secretion in duodenal ulcer patients.

Authors:  J Butt; T Yoshida; B Fleshler
Journal:  Am J Dig Dis       Date:  1977-04

9.  A comparison of Boots and GIH secretin as stimuli of pancreatic secretion in human subjects with or without chronic pancreatitis.

Authors:  L V Gutierrez; J H Baron
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.